Insulet | PODD - PE Price to Earnings

Stock Price
251.24
Daily Change
0.02 0.01%
Monthly
-11.38%
Yearly
-11.75%
Q1 Forecast
247.93

Insulet reported $60.7 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Abbott USD 30.71 14.41 Dec/2025
Align Technology USD 18.15 11.21 Sep/2025
AtriCure USD 34.15 2.7 Jun/2022
Avanos Medical USD 7.23 328.11 Sep/2025
Baxter International USD 17.1 4.46 Sep/2025
Becton, Dickinson and Co. USD 132.35 109.91 Sep/2025
Boston Scientific USD 44.52 2.5 Sep/2025
Cardinal Health USD 19.87 3.11 Sep/2025
Cooper Companies USD 24.48 10.29 Sep/2025
Dexcom USD 35.46 30.17 Sep/2025
Edwards Lifesciences USD 29.92 0.5 Sep/2025
Eli Lilly USD 49.87 12.87 Sep/2025
Globus Medical USD 18.82 0.6 Sep/2025
ICU Medical USD 361.42 280.76 Jun/2022
Insulet USD 60.7 2.04 Sep/2025
Integra LifeSciences USD 7.08 55.94 Sep/2025
J&J USD 23.62 0.86 Dec/2025
Masimo USD 104.24 103.55 Sep/2025
Medtronic USD 21.44 0.62 Sep/2025
Merit Medical Systems USD 39.12 6.7 Sep/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Solventum Corp USD 85.23 56.9 Sep/2025
Stryker USD 32.13 2.69 Dec/2025
Tandem Diabetes Care USD 681.05 189.32 Mar/2022
Teleflex USD 11.49 25.15 Sep/2025
West Pharmaceutical Services USD 37.97 6.94 Sep/2025
Zimmer Biomet Holdings USD 21.41 4.35 Sep/2025